On a segment basis, service revenue for the first quarter of Fiscal Year 2014 was $332.6 million in Clinical Research Services (CRS), $53.5 million in PAREXEL Consulting and Medical Communications Services (PCMS), and $63.1 million in Perceptive Informatics, Inc.
Backlog at the end of September 2013 was approximately $4.63 billion, an increase of 2.2% year-over-year. The reported backlog included gross new business wins in the quarter of $563.7 million, cancellations of $169.7 million, and a positive impact from foreign exchange rates of $80.6 million. The net book-to-bill ratio was 0.88 in the quarter.
The Company issued forward-looking guidance for the second quarter of Fiscal Year 2014 (ending December 31, 2013) and reconfirmed prior guidance for Fiscal Year 2014 as described in the text and chart below. The guidance takes into account recent exchange rates, revised tax rates, and the Company's updated overall outlook.
The Company's guidance is detailed below: Guidance Issued 10/29/13
Guidance Issued 8/7/13Q2 FY 2014 Revenue
$475 - $480 million
N/AQ2 FY 2014 GAAP EPS
$0.46 - $0.50
N/AFY 2014 Revenue
$1.890 - $1.920 billion
$1.890 - $1.920 billionFY 2014 GAAP EPS
FY 2014 non-GAAP EPS
$1.95 - $2.11
$1.95 - $2.11
In addition to the financial measures prepared in accordance with GAAP, the Company uses certain non-GAAP financial measures. The Company believes that presenting the non-GAAP financial measures contained in this press release assists investors and others in gaining a better understanding of its core operating results and future prospects, especially when comparing such results to previous periods or forecasted guidance, because such measures exclude items tha
|SOURCE PAREXEL International Corporation|
Copyright©2012 PR Newswire.
All rights reserved